Carl S - Search Results

1

A placebo controlled study of mycophenolate mofetil used in combination with cyclosporine and corticosteroids for the prevention of acute rejection in renal allograft recipients: 1-year results. The European Mycophenolate Mofetil Cooperative Study Group.

Wiesel M, Carl S. Wiesel M, et al. Among authors: carl s. J Urol. 1998 Jan;159(1):28-33. doi: 10.1016/s0022-5347(01)64000-x. J Urol. 1998. PMID: 9400430 Clinical Trial.

2

Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.

Carl S, Wiesel M. Carl S, et al. Transplant Proc. 1997 Nov;29(7):2932-5. doi: 10.1016/s0041-1345(97)00734-3. Transplant Proc. 1997. PMID: 9365619 Clinical Trial. No abstract available.

3

Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept.

Carl S, Dörsam J, Mandelbaum A, Staehler G, Wiesel M. Carl S, et al. Transplant Proc. 1998 Jun;30(4):1236-7. doi: 10.1016/s0041-1345(98)00224-3. Transplant Proc. 1998. PMID: 9636502 Clinical Trial. No abstract available.

4

[Mycophenolate mofetil (MMF) for prevention of kidney transplant rejection. A new immunosuppressive agent. International Mycophenolate Mofetil Study Group].

Carl S, Wiesel M, Staehler G. Carl S, et al. Urologe A. 1998 May;37(3):282-6. doi: 10.1007/s001200050185. Urologe A. 1998. PMID: 9646426 Clinical Trial. German.

5

Rescue therapy with interleukin-2 receptor antibody in high risk kidney transplant patients: a 3-year follow-up study.

Carl S, Wiesel M, Daniel V, Dörsam J, Opelz G, Staehler G. Carl S, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):320-2. doi: 10.1016/s0041-1345(96)00283-7. Transplant Proc. 1997. PMID: 9123020 No abstract available.

6

Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients.

Süsal C, Wiesel M, Schönemann C, Groth J, Carl S, Staehler G, May G, Opelz G. Süsal C, et al. Among authors: carl s. Transplant Proc. 1997 Feb-Mar;29(1-2):1444-6. doi: 10.1016/s0041-1345(96)00551-9. Transplant Proc. 1997. PMID: 9123373 No abstract available.

7

[The clinical significance of renal cell carcinoma in dialysis dependent patients in comparison with kidney transplant recipients].

Wiesel M, Carl S, Drehmer I, Hofmann WJ, Zeier M, Staehler G. Wiesel M, et al. Among authors: carl s. Urologe A. 1997 Mar;36(2):126-9. doi: 10.1007/s001200050077. Urologe A. 1997. PMID: 9199039 German.

8

Living donor nephrectomy: a 28-year experience at Heidelberg University.

Wiesel M, Carl S, Staehler G. Wiesel M, et al. Among authors: carl s. Transplant Proc. 1997 Nov;29(7):2769. doi: 10.1016/s0041-1345(97)00670-2. Transplant Proc. 1997. PMID: 9365555 No abstract available.

9

Outcome of children and adolescents with recurrent nephrotic syndrome and focal segmental glomerulosclerosis after renal transplantation.

Carl S, Wiesel M, Wühl E, Mehls O, Schaefer F, Staehler G. Carl S, et al. Transplant Proc. 1997 Nov;29(7):2795-6. doi: 10.1016/s0041-1345(97)00681-7. Transplant Proc. 1997. PMID: 9365566 No abstract available.

10

[Salvage therapy with anti-IL-2 receptor antibodies in high-risk kidney transplant patients].

Carl S, Wiesel M, Deiss JM, Daniel V, Opelz G, Staehler G. Carl S, et al. J Urol (Paris). 1997;103(1-2):7-9. J Urol (Paris). 1997. PMID: 9765770 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters